Evidence map›Paper›PMID 33552872›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Surface-Anchored Nanogel Coating Endows Stem Cells with Stress Resistance and Reparative Potency via Turning Down the Cytokine-Receptor Binding Pathways.

Ling Zhang, Guowu Liu, Kaiqi Lv, Jinxia Xin, Yingchao Wang, Jing Zhao, Wangxing Hu, Changchen Xiao, Keyang Zhu, Lianlian Zhu and 9 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Ling ZhangDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Guowu LiuCancer Institute (Key Laboratory of Cancer Prevention and Intervention National Ministry of Education), The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Kaiqi LvDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Jinxia XinCancer Institute (Key Laboratory of Cancer Prevention and Intervention National Ministry of Education), The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Yingchao WangDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Jing ZhaoDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Wangxing HuDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Changchen XiaoDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Keyang ZhuDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Lianlian ZhuDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Jinliang NanDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Ye FengInstitute of Translational Medicine Zhejiang University Hangzhou 310029 China.
Huaying ZhuDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Wei ChenDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Wei ZhuDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Jianyi ZhangDepartment of Biomedical Engineering University of Alabama at Birmingham Birmingham AL 35294 USA.
Jian'an WangDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Ben WangCancer Institute (Key Laboratory of Cancer Prevention and Intervention National Ministry of Education), The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.
Xinyang HuDepartment of Cardiology, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 China.ORCID https://orcid.org/0000-0002-6699-8470
Zhejiang Lab · CNZhejiang Cancer Hospital · CNUniversity of Alabama at Birmingham · USZhejiang Chinese Medical University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cell-based therapy has great potential in regenerative medicine. However, the survival and engraftment rates of transplanted stem cells in disease regions are poor and limit the effectiveness of cell therapy due to the fragility of stem cells. Here, an approach involving a single-cell coating of surface-anchored nanogel to regulate stem cell fate with anti-apoptosis capacity in the hypoxic and ischemic environment of infarcted hearts is developed for the first time. A polysialic acid-based system is used to anchor microbial transglutaminase to the external surface of the cell membrane, where it catalyzes the crosslinking of gelatin. The single-cell coating with surface-anchored nanogel endows mesenchymal stem cells (MSCs) with stress resistance by blocking the activity of apoptotic cytokines including the binding of tumor necrosis factor α (TNFα) to tumor necrosis factor receptor, which in turn maintains mitochondrial integrity, function and protects MSCs from TNF

Indexed as

cell surface engineeringcell therapyengraftmentheart repairstem cells

Identifiers

PMID33552872
PMCPMC7856906
OpenAlexW3158556145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.